Cargando…
Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism?
Autores principales: | Vavlukis, Marija, Kotlar, Irina, Taravari, Hajber, Poposka, Lidija, Kedev, Sasko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512203/ https://www.ncbi.nlm.nih.gov/pubmed/28680014 http://dx.doi.org/10.14744/AnatolJCardiol.2017.7805 |
Ejemplares similares
-
Antiphospholipid Syndrome - A Case Report of Pulmonary Thromboembolism, Followed with Acute Myocardial Infarction in Patient with Systemic Sclerosis
por: Vavlukis, Marija, et al.
Publicado: (2015) -
Diffuse Arterial Thrombosis as a First Manifestation of Occult Malignancy
por: Vavlukis, Marija, et al.
Publicado: (2016) -
Rivaroxaban treatment for cancer-associated venous thromboembolism in a patient with heparin-induced thrombocytopenia: a case report
por: Le, Ke-Jia, et al.
Publicado: (2019) -
Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
Publicado: (2020) -
Age and Gender Impact on Heart Rate Variability towards Noninvasive Glucose Measurement
por: Stojmenski, Aleksandar, et al.
Publicado: (2023)